Wogonin external preparation and application thereof in treatment of atopic dermatitis
The invention discloses a wogonin external preparation and application thereof in treatment of atopic dermatitis, the wogonin external preparation contains wogonin as an active ingredient, and pharmaceutic adjuvants are added to prepare an external preparation for skin and mucosa. The external preparation can significantly improve the pathological indications of mouse atopic dermatitis skin tissues, reduce the transcriptional level of inflammatory factors at lesion sites, significantly reduce the percutaneous dehydration degree of the lesion sites of the mouse atopic dermatitis skin tissues and repair the skin barrier, and has a good effect on atopic dermatitis..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Europäisches Patentamt - (2024) vom: 12. Jan. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
KOU SHUMENG [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-12, Last update posted on www.tib.eu: 2024-03-18, Last updated: 2024-03-22 |
---|
Patentnummer: |
CN117379417 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA001032410 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | EPA001032410 | ||
003 | DE-627 | ||
005 | 20240322141023.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240322s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA001032410 | ||
035 | |a (EPA)CN117379417 | ||
035 | |a (EPA)89466618 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a KOU SHUMENG |e verfasserin |4 aut | |
245 | 1 | 0 | |a Wogonin external preparation and application thereof in treatment of atopic dermatitis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-12, Last update posted on www.tib.eu: 2024-03-18, Last updated: 2024-03-22 | ||
520 | |a The invention discloses a wogonin external preparation and application thereof in treatment of atopic dermatitis, the wogonin external preparation contains wogonin as an active ingredient, and pharmaceutic adjuvants are added to prepare an external preparation for skin and mucosa. The external preparation can significantly improve the pathological indications of mouse atopic dermatitis skin tissues, reduce the transcriptional level of inflammatory factors at lesion sites, significantly reduce the percutaneous dehydration degree of the lesion sites of the mouse atopic dermatitis skin tissues and repair the skin barrier, and has a good effect on atopic dermatitis. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a YE SI |4 aut | |
700 | 0 | |a LI PENGHUI |4 aut | |
700 | 0 | |a SUN ZHONGYING |4 aut | |
700 | 0 | |a GUO QINGLONG |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 12. Jan. |
773 | 1 | 8 | |g year:2024 |g day:12 |g month:01 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89466618/publication/CN117379417A1?q=CN117379417 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2024 |b 12 |c 01 |